Skip to main content
Loading ResearchHub…
References for Multitarget Therapy With Rituximab Plus Mycophenolate Mofetil Versus Rituximab Monotherapy in Systemic Sclerosis–Associated Interstitial Lung Disease | ResearchHub - ResearchHub